Skip to content

Clinical trials

Terminated Kidney Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Status: Terminated Country / region: United States Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20053
20061
20071
20085
20092
20102
20111
20143
20153
20162
20172
20181
20192
20202
20212
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital3
Celldex Therapeutics3
Amgen2
Aravive, Inc.2
Astellas Pharma Inc2
Goldfinch Bio, Inc.2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
University of Alabama at Birmingham2
Albert Einstein Healthcare Network1
Angiotech Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases39
Carcinoma, Renal Cell6
Kidney Failure, Chronic6
Kidney Neoplasms6
Renal Insufficiency6
Renal Insufficiency, Chronic5
Acute Kidney Injury4
Urologic Diseases4
Urologic Neoplasms4
Diabetes Mellitus, Type 23

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.